StockData
Bioxytran, Inc logo

Bioxytran, Inc (BIXT) stock

BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.02−0.00 (-3.95%)

Close on Oct 19, 2026Market cap $2.56MP/E –Yield –

Bioxytran total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Bioxytran's total debt was $48.07K at Jun 30, 2025. For fiscal 2024 it was $48.00K, up 92.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$48.00K+92.0%
FY2017Dec 31, 2017$25.00K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2025Jun 30, 2025$48.07K+92.3%
Q1 FY2025Mar 31, 2025$48.00K+92.0%
Q4 FY2024Dec 31, 2024$48.00K+92.0%
Q1 FY2021Mar 31, 2021$420.75K–
Q2 FY2018Jun 30, 2018$25.00K–
Q1 FY2018Mar 31, 2018$25.00K–
Q4 FY2017Dec 31, 2017$25.00K–

More Bioxytran figures

See a number that looks wrong?